AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator

 AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator

AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator

Shots:

  • AbbVie will develop a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator licensed from CF foundation and advance it into clinical development to be used in combination treatment for CF
  • The focus of the agreement is to identify new therapeutic options for people with CF by utilizing the clinical expertise to advance the SoC in CF
  • AbbVie is currently investigating the combination of potentiator and corrector molecules, targeting CFTR to improve outcomes for people with CF

Click here to­ read full press release/ article | Ref: AbbVie | Image: Powderbulksolid

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post